FemTech: Oova Launches New Fertility Membership Model

FemTech: Oova Launches New Fertility Membership Model

What You Should Know: 

  • Femtech solutions company OOVA launches its brand NEW fertility membership model designed to support and empower women by providing advanced at-home hormone testing and full-circle assistance along their fertility journey with unmatched ease, for only $99/mo.  
  • OOVA, the first and only OTC hormone test that quantitatively measures two essential hormones in a single, at-home urine test, provides women with insights into their ovulation patterns to increase the probability of conception. 

The OOVA Fertility Membership

Only 1 in 10 women flow on a 28-day cycle, and monitoring + understanding your cycle patterns can take months and requires more than a single at-home test. Current at-home ovulation trackers operate on that baseline, consequently providing false-positive and futile results. OOVA is FDA-registered, HIPAA compliant, and the only test on the market to measure luteinizing hormone (LH) and progesterone (PdG) in real-time, providing women with daily insights and actionable advice to optimize their chances of conception.

The new OOVA fertility membership includes: 

  • Monthly supply of 15 test sticks
    • Measuring 30 hormones with lab-quality accuracy
  • Access to the OOVA provider network
    • Experienced healthcare providers and 1:1 consultations with OOVA’s hormone experts to help you turn data into actionable insights
  • Sync + share results with your doctor in real time 
    • The HIPAA compliant platform allows your doctor to access your hormone results virtually. 
    • The average doctor’s appointment is 6.5 minutes long. Coming to your appointment armed with data allows you to advocate for yourself and streamline your journey to conception. 
  • Support within the OOVA community + Monthly webinars
    • Connect with other women on their own fertility journeys for a support system of people who understand infertility struggles.